Home LiteratureArticle Details
PMID: 10469636 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Induction of cyclin-dependent kinase inhibitors and G(1) prolongation by the chemopreventive agent N-acetylcysteine.

Carcinogenesis ·Vol. 20 ·No. 9 ·1999-09-00 ·Pages 1869-72

Liu M, Wikonkal NM, Brash DE

Abstract

Cyclin-dependent kinase (cdk) inhibitors, such as p16(INK4a) and p21(WAF1/CIP1), often inhibit G(1) cyclin kinases and result in G(1) arrest. It has been suggested that p21(WAF1/CIP1) may also play a role in other chemopreventive activities such as DNA repair, slowdown of DNA replication and induction of cellular differentiation. In this report we demonstrate that the antioxidant N-acetylcysteine (NAC), a well-known chemopreventive agent, induces p16(INK4a) and p21(WAF1/CIP1) gene expression and prolongs cell-cycle transition through G(1) phase. A portion of the G(1) arrest by NAC is governed by p16(INK4a); it is independent of p53. NAC's usual mechanism of increasing intracellular glutathione level is not required for the G(1) arrest. An antioxidant whose action is limited to scavenging radicals, Trolox, does not induce G(1) arrest. Taken together, these results suggest a potential novel molecular basis for chemoprevention by NAC.

MeSH Terms
Acetylcysteine/pharmacology Animals Anticarcinogenic Agents/pharmacology Antioxidants/pharmacology Cell Cycle/drug effects Cell Line/drug effects,metabolism Chromans/pharmacology Cyclin-Dependent Kinase Inhibitor p16/biosynthesis Cyclin-Dependent Kinase Inhibitor p21 Cyclins/biosynthesis,genetics Fibroblasts/drug effects,metabolism Free Radical Scavengers/pharmacology G1 Phase/drug effects Gene Expression Regulation/drug effects Gene Expression Regulation, Neoplastic/drug effects Genes, p16/drug effects Glutathione/physiology Humans Keratinocytes/drug effects,metabolism Mice Models, Biological Neoplasm Proteins/biosynthesis,genetics Papilloma/pathology Skin Neoplasms/pathology Tumor Cells, Cultured/drug effects,metabolism Tumor Suppressor Protein p53/physiology
Chemicals
Anticarcinogenic Agents Antioxidants CDKN1A protein, human Cdkn1a protein, mouse Chromans Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p21 Cyclins Free Radical Scavengers Neoplasm Proteins Tumor Suppressor Protein p53 Glutathione 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid Acetylcysteine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Liu M
Department of Therapeutic Radiology and Department of Genetics, Yale University School of Medicine, New Haven, CT 06520-8040, USA.
Wikonkal N M
Brash D E
Article Info
Journal
Carcinogenesis
Abbr.
Carcinogenesis
ISSN
0143-3334
Published
1999-09-00
Pages
1869-72
Language
English
Region
England
NLM ID
8008055
Subset
IM
Grants
NCI NIH HHS · CA55737 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com